PA
ANIK icon

Perceptive Advisors’s Anika Therapeutics ANIK Stock Holding History

Perceptive Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-144,067
Closed -$3.44M – 115
2013
Q3 		$3.44M Buy
+144,067
New +$3.23M 0.28% 48

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Perceptive Advisors's ANIK Position: Q4 2013 in Review

Perceptive Advisors sold out of Anika Therapeutics (ANIK) in Q4 2013, closing a stake of 144,067 shares — an estimated $3.44M sold.

Perceptive Advisors first reported a position in ANIK in Q3 2013 and held it in 1 quarter. The position peaked at $3.44M in Q3 2013. 146 funds tracked by Wall St. Rank hold ANIK as of Q4 2013.

  • Perceptive Advisors reported no remaining Anika Therapeutics position as of Q4 2013 after selling out during the quarter.
  • Perceptive Advisors sold 144,067 Anika Therapeutics shares in Q4 2013, an estimated $3.44M.
  • Perceptive Advisors first reported a position in Anika Therapeutics in Q3 2013 and held it in 1 quarter.
  • Perceptive Advisors's Anika Therapeutics position peaked at $3.44M in Q3 2013.
  • 146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2013.

Based on Perceptive Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.